Reference: GILA/ID/IPO-003/SPACE
Board seat: Independent Director, Non-Executive
Primary board location: Bengaluru, with launch-partner and ground-station visits
Meeting model: Eight board/committee cycles during filing and major mission gates
Mandate type: Pre-IPO Board Build & IPO Readiness
Status: Confidential live-search specification; client identity released only after conflict clearance and NDA.
The anonymised enterprise
A private space-technology company combining earth-observation data, proprietary analytics and a small-satellite constellation assembled through Indian and overseas partners.
Annualised contracted value is in the ₹900–1,400 crore range, but recognised revenue is materially lower because missions and government acceptance milestones govern recognition. Three late-stage investors hold protective rights and are preparing for a mainboard listing.
The board problem and strategic reason for appointment
The board must distinguish durable data-platform economics from mission-dependent project revenue. Export controls, remote-sensing permissions, dual-use customers, orbital capacity and claims about proprietary AI will receive far more scrutiny in a prospectus than in venture fundraising.
The board is not buying a credential. It is appointing an independent decision-maker who can convert this problem into a governed sequence of choices, evidence and accountability. Success will be judged by the quality of decisions and control improvement, not by the number of recommendations made.
Board position, authority and interfaces
Chair of Technology & Risk, member of Audit for revenue-recognition and intangible-asset matters, and independent participant in the IPO disclosure committee.
The appointee will have direct, unfiltered access to the Company Secretary and to the relevant control-function leaders. Any advisory support requested by the board must remain management-executed: the director sets questions, tolerances and evidence standards, but does not become an executive or consultant.
First 12–18 month strategic charter
- Approve a mission-assurance and launch-failure risk framework, including insurance and customer remedies; test whether analytics ARR, backlog and data-latency KPIs are consistently defined and auditable; map export-control, geospatial, spectrum and customer-use permissions across jurisdictions; review capitalisation of development expenditure, satellite useful lives and impairment triggers
- Convert the listing workplan into a board-owned assurance map: each offer-document assertion, restated-financial dependency, material contract, litigation disclosure and KPI must have an executive owner, an independent challenge point and dated evidence.
- Create a post-listing operating rhythm before filing: quarterly close rehearsals, UPSI controls, disclosure escalation, analyst-communication discipline, committee calendars and a board-paper standard capable of surviving public scrutiny.
Decision profile sought
Essential evidence
- Space, aerospace, geospatial or mission-critical technology leadership; public-company audit/risk fluency; experience governing intangible-heavy revenue and government customers
Differentiators
- Launch insurance, export-control or satellite-operations exposure; a completed deep-tech IPO or cross-border listing cycle
GILA will assess completed Indian capital-markets exposure, judgement under filing pressure, and the ability to distinguish genuine governance readiness from transaction theatre. Candidates should expect a case discussion based on an ambiguous board decision from this mandate, not a career-history interview alone.
Independence, suitability and downside diligence
The search will apply Section 149(6), Sections 164–165, Schedule IV and the applicable listing or sector rules to the entity’s legally verified status at the appointment date. Databank/proficiency status, listed-entity directorship and committee ceilings, pecuniary relationships, relatives’ interests, recent audit/advisory work and interlocking directorships will be checked. The appointment is subject to formal legal and secretarial confirmation; this posting is not a substitute for that determination.
Mandate-specific screens: Current ties to launch providers, competing constellations or defence end-users that compromise neutrality; investment in customer start-ups; recent paid promotion of the company or sector.
Before accepting the seat, the candidate will receive under NDA the latest board composition, committee charters, material litigation/regulatory schedule, related-party map, last audited accounts, current D&O policy and the specific risk papers necessary to make an informed liability assessment.
Twelve-month outcomes
The board expects a board with a defensible pre-filing record, no last-minute committee architecture, and a credible first-year listed-company calendar. For this particular seat, the evidence will be:
- Auditable definitions for backlog, ARR and constellation availability; board-approved mission loss and cyber-resilience scenarios; licence/export-control matrix cleared before offer-document diligence
Commitment, protection and economics
- Expected load: 28–36 days in the pre-IPO year plus availability around launches.
- Terms: Five-year term; cash-only independent-director economics; mission-period D&O and access to independent export-control advice.
- Protection: Appointment letter, deed of indemnity where legally available, appropriate D&O cover including discovery/run-off terms, access to independent advice under the board-approved protocol, and complete minuting of dissent.
- Equity: No stock options where the appointment is legally an independent-director seat subject to Section 149(9). Any private-company structure outside that perimeter will be expressly classified and separately advised; no equity is implied by this posting.
Search process
Conflict pre-clearance → GILA/SYMPHONY™ board-fit interview → mandate case → document-led diligence under NDA → references from board peers and control functions → NRC/owner interviews → statutory, regulatory and reputation checks → board recommendation. Candidate consent, disclosures and appointment approvals will follow the law and the entity’s constitutional documents.